Sheila Keating, PhD MSPH

Sheila Keating, PhD MSPH, has a diverse work experience spanning over 25 years. Sheila is currently employed at GigaGen Inc, where they serve as the VP of Immunology. In this role, they are responsible for establishing GCP/GCLP practices for drug discovery and product development, conducting translational research, data analysis, scientific writing, leadership, and public speaking.

Prior to their current position, Keating worked at the Blood Systems Research Institute, where they held various roles from 2008 to 2018. Sheila started as an Affiliate Investigator and later became a Senior Scientist. Sheila'sfinal role at the institute was Director of the Core Immunology Lab. During their time there, they focused on the development of new diagnostics for HIV detection and the identification of immune mediators in HIV, HBV, and HCV.

Keating also has experience in academia. Sheila is an Adjunct Associate Professor at the University of California, San Francisco since 2017. Additionally, they worked as a Postdoctoral Research Fellow at the Institute of Child Health University College London from 2005 to 2007. During this time, they studied memory B cell responses to Pneumococcal vaccines in the elderly.

In terms of their education, Keating conducted their PhD research at the University of Oxford from 2002 to 2005. Sheila'sresearch focused on immune correlates of protection of new malaria vaccine candidates. Sheila also worked as a Research Assistant/PhD during this time. Furthermore, they gained experience as a Senior Research Program Coordinator at Johns Hopkins School of Medicine from 1999 to 2002, working on optimizing laboratory techniques for studying early immune responses to acute HIV infection.

Keating's work experience also includes a role as a Research Assistant at the Henry M Jackson Foundation from 1998 to 1999, where they focused on characterizing co-receptor usage and polymorphisms affecting HIV tropism. Sheila began their career as an Administrative Assistant at the University of Connecticut Health Center from 1995 to 1997, supporting research staff investigating heat shock protein-based cancer immunotherapies.

Overall, Sheila Keating has a strong background in immunology, with extensive experience in drug discovery, product development, translational research, diagnostics, and scientific writing. Sheila'swork has primarily focused on infectious diseases such as HIV, HBV, HCV, and pneumococcal infections, as well as vaccine development. Sheila has demonstrated leadership skills and the ability to collaborate with interdisciplinary teams.

Sheila Keating, PhD MSPH, has an extensive education history. Sheila started their academic journey in 1988 at Newton North HS, where they obtained their High School Diploma. Following this, they attended the College of the Holy Cross from 1990 to 1994 and earned a Bachelor of Arts degree with a focus on Biology. Building on their undergraduate studies, they pursued higher education at Tulane University from 1998 to 1999, where they obtained a Master of Science in Public Health (MSPH) degree specializing in Tropical Medicine. Lastly, they enrolled in the Open University at Oxford University from 2002 to 2005, culminating in the completion of their PhD in Immunology. Overall, Sheila Keating's education history demonstrates their dedication to the field of biology and their specific interest in immunology and tropical medicine.